Home/Filings/4/0001209191-19-009103
4//SEC Filing

Di Donato Brian 4

Accession 0001209191-19-009103

CIK 0001070336other

Filed

Feb 10, 7:00 PM ET

Accepted

Feb 11, 6:25 PM ET

Size

5.4 KB

Accession

0001209191-19-009103

Insider Transaction Report

Form 4
Period: 2019-02-11
Di Donato Brian
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to buy)

    2019-02-11+500,000500,000 total
    Exercise: $2.29Exp: 2029-02-11Common Stock (500,000 underlying)
Footnotes (1)
  • [F1]This option vests as to 25% of the original number of shares on the first anniversary of the grant date and as to an additional 6.25% of the original number of shares at the end of each successive three-month period thereafter.

Issuer

ACHILLION PHARMACEUTICALS INC

CIK 0001070336

Entity typeother

Related Parties

1
  • filerCIK 0001766498

Filing Metadata

Form type
4
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 6:25 PM ET
Size
5.4 KB